Inflammation induced during infection can both promote and suppress immunity. This contradiction suggests that inflammatory cytokines affect the immune system in a context-dependent manner. Here we show that nonspecific bystander inflammation conditions naive CD4 + T cells for enhanced peripheral Foxp3 induction and reduced effector differentiation. This results in inhibition of immune responses in vivo via a Foxp3-dependent effect on antigen-specific naive CD4 + T cell precursors. Such conditioning may have evolved to allow immunity to infection while limiting subsequent autoimmunity caused by release of self-antigens in the wake of infection. Furthermore, this phenomenon suggests a mechanistic explanation for the idea that early tuning of the immune system by infection affects the long-term quality of immune regulation.
The adaptive immune system has evolved to provide effective longterm resistance to a wide range of microbial infections. However, the vigor of the immune response must be balanced by mechanisms that prevent damage to self-tissues. These mechanisms include intrinsic negative feedback pathways that 'shut down' inflammatory signals 1, 2 , as well as mobilization of regulatory Foxp3 + T cells (T reg cells) that can suppress effector T cell (T eff cell) responses 3 . The peripheral differentiation of naive CD4 + T cells into Foxp3 + T reg cells serves to enhance the functional capacity of the total T reg cellular pool by broadening the clonal repertoire 4 . This process critically limits immunopathology in tissues and at mucosal sites by induction of antigen-specific T reg cells that enforce tolerance to self-antigens or innocuous foreign antigens 5 . Peripheral development of T reg cells has an important role in immune tolerance overall, but it is unclear how antigen-specific T reg cells from naive CD4 + T cell precursors are modulated during the course of an acute inflammatory response such as to viral infection. Viral infection and immunostimulatory agents such as Toll-like receptor (TLR) agonists promote T cell responses in part by production of cytokines 6 . Inflammatory cytokines and type I interferon (IFN-I) released by TLR stimulation enhance T eff cell responses and counteract development and function of T reg cells that express the transcription factor Foxp3 (refs. [7] [8] [9] . TLR agonists such as the 'viral mimic' polyinosinic:polycytidylic acid (poly(I:C)) generate IFN-I inflammation and are promising candidates to augment vaccination 10 . However, inflammatory cytokines also generate bystander signals to naive T cells not specific for viral antigens 11 . This may act to breach activation thresholds for self-reactive T cells, supporting the notion that infection can trigger autoimmunity 12, 13 . In contrast, antiviral inflammatory responses have also been shown to cause immunosuppression 12, 14 . This contradiction suggests that inflammatory cytokines may affect T cell responses in a flexible manner, with the outcome dependent on the context of T cell response.
Here we show that nonspecific bystander inflammation conditions naive CD4 + T cells for diminished effector response and enhanced induction of Foxp3 in response to subsequent antigen encounter. We refer to these T cells as inflammation-conditioned naive T ( IC T N ) cells. The phenotypic change is directed by antiviral inflammatory signals and depends on IFN-I signaling. Naive CD4 + T cells exposed to IFN-I bystander inflammation showed changes in molecular pathways that diminished T eff cell development to 'favor' de novo T reg cell development from naive CD4 + T cell precursors, thereby affecting subsequent antigen-specific immune responses. These data suggest that naive CD4 + T cells integrate signals over time during an immune response to modulate effector and regulatory cellular responses over the course of inflammation.
RESULTS

Effects of inflammation on Foxp3 + T reg cells and asthma
To determine the role of nonspecific inflammatory stimuli on CD4 + T cells, we induced systemic inflammation in mice by intraperitoneal injection of poly(I:C). After this treatment, we observed a notable increase in frequency and total numbers of functional Foxp3 + CD4 + T cells in the spleen, peaking ~7 d after injection ( Supplementary  Fig. 1a ). Foxp3 + T reg cells sorted from mice treated with poly(I:C) showed similar in vitro functional suppressive activity and ex vivo phenotype to that of control cells from PBS-treated mice ( Supplementary  Fig. 1b-d and data not shown) and did not produce inflammatory cytokines upon ex vivo restimulation ( Supplementary Fig. 1e ). Fig. 2a ). (a-c) Airway response of mice challenged with intranasal OVA after OVA immunization in the context of PBS or poly(I:C) (pIC) pretreatment, as indicated by total pulmonary cell counts for mononuclear cells (a), eosinophils (b) or neutrophils (c). Each symbol represents a single mouse. Data are representative of two independent experiments, n ≥ 4 mice per group. (d) Growth of OVA-bearing A20-tGO tumor after OVA immunization in the context of PBS or pIC pretreatment. Dotted lines represent individual mice, thick lines represent mean tumor size for all mice. Data are compiled from two independent experiments, n = 11 mice per group. *P < 0.05, **P < 0.001, Student's two-tailed t-test (a-c) or two-way ANOVA (d).
When poly(I:C) was delivered directly (intranasally) to the pulmonary mucosa, we observed increased frequencies and numbers of Foxp3 + T reg cells in the lungs of mice ( Fig. 1a) . To determine how this nonspecific bystander inflammatory effect affected a primary immune response in the mucosal environment, we adapted a model of antigen-specific priming via pulmonary mucosa after intranasal poly(I:C) treatment 15 (Online Methods and Supplementary Fig. 1f ). All treatments resulted in a trend of elevated pulmonary cellular infiltration in poly(I:C)-treated mice as compared to PBS-treated negative controls ( Fig. 1b) . Primary antigen delivery resulted in eosinophil accumulation as well as other measures of pulmonary inflammation in positive control (PBS pretreated) mice, and this response was completely inhibited in mice pretreated with poly(I:C) ( Fig. 1c) . This effect was not due to skewing of lung infiltration toward a neutrophilic-based response ( Supplementary Fig. 1g ), which indicates that bystander inflammation shut down, rather than qualitatively altered, the airway inflammatory response 16 .
Immunization after inflammation diminishes recall response
We next tested the impact of systemic bystander inflammation on antigen-specific recall immune responses. Mice were treated with PBS or poly(I:C) via intraperitoneal injection, followed by immunization with subcutaneous ovalbumin (OVA) emulsified in incomplete Freund's adjuvant (IFA). The mice were challenged with antigen 7-10 d later either via the airways or implanted with antigen-expressing tumor, and airway inflammation or tumor growth were assessed (Online Methods and Supplementary Fig. 2a ). Upon intranasal antigen challenge, mice that were primed with antigen after bystander inflammation showed lower total pulmonary cellularity ( Fig. 2a ) and eosinophil ( Fig. 2b) and neutrophil ( Fig. 2c ) infiltration than controls, which indicates that the immune-suppressive effect of poly(I:C)-mediated inflammation can inhibit antigen-specific mucosal recall responses that are anatomically disparate. Similarly, poly(I:C)-treated mice showed a modest but significant decrease in tumor resistance after challenge with OVA-expressing A20 lymphoma 17 , compared to controls ( Fig. 2d and Supplementary Fig. 2b) . These observations show that qualitatively diverse endogenous antigen-specific immune responses are suppressed in vivo when priming occurs after nonspecific bystander inflammation.
Inflammation alters molecular pathways in naive CD4 + T cells
The marked impact of nonspecific inflammation on antigen-specific responses and increase in Foxp3 + T reg cells, at mucosal sites in particular, suggested a potential impact of bystander inflammation on the priming of naive T cells. To determine how nonspecific bystander inflammation affects naive CD4 + T cells, we treated recombination-activated gene-deficient DO11.10 T cell-antigen receptor (TCR)-transgenic (DR) mice with poly(I:C) and used them as a source of naive non-T reg CD4 + T cells stimulated with bystander inflammation in the absence of cognate antigen (i.e., IC T N cells) ( Supplementary Fig. 3a) .
We first investigated the ex vivo expression of genes associated with regulation of T cell activation. Negative signal feedback molecules, such as Socs1 (encoded by Socs1) and microRNA 155 (MiR155), modulate effector T cell responses and support T reg cell stability and function 18, 19 . Expression of Socs1 and Mir155 was higher in directly isolated ex vivo IC T N DR CD4 + T cells than in controls from PBS-treated mice ( Fig. 3a,b ). Next, we examined mTOR signaling in antigen-stimulated npg receptor signaling pathways results in enhanced Foxp3 + T reg cell (as opposed to T eff cell) differentiation 20, 21 . Upon antigen stimulation, p-S6 was reduced in IC T N DR cells ( Fig. 3c) . We also observed a modest but consistent reduction in AKT activation ( Supplementary  Fig. 3b ). Additionally, after antigen stimulation, expression of Il12rb2 mRNA and T-bet protein 22, 23 , which enable effector T H 1 differentiation and repress T reg cell differentiation, was substantially reduced in IC T N DR cells ( Fig. 3d,e ). These changes in cellular responsiveness occurred despite similar rates of proliferation and cell survival ( Supplementary Fig. 3c,d) . Together, these data suggest that nonspecific bystander inflammation conditions naive T cells into a refractory molecular 'state' that could dampen T cell activation.
IC T N cells 'favor' T reg cell differentiation
The impact of bystander inflammation on molecular pathways after CD4 + T cell stimulation suggested that the de novo differentiation of T eff and T reg cells may be affected in response to antigen. After TCR stimulation in the presence of transforming growth factor-β (TGF-β), IC T N DR cells showed ~5-fold higher frequency of Foxp3 + cells than did control cells from PBS-treated mice (Fig. 4a) . This increase did not require the continued presence of antigen-presenting cells (APCs) ( Supplementary Fig. 4a ), which indicates that bystander inflammation imposed a cell-intrinsic physiological state on the naive T cells that resulted in enhanced de novo T reg cell generation after encounter with antigen. We also observed this effect with isolated naive CD4 + T cells from poly(I:C)-treated wild-type BALB/c mice ( Fig. 4b) ,
which indicates that this effect was not an artifact of a transgenic TCR. Notably, these effects were most prominent at suboptimal TGF-β concentrations for T reg cell differentiation. Foxp3 promoter methylation was similar among naive CD4 + T cells from IC T N and control DR mice, as well as BALB/c mice, which indicates that this represented conversion of a 'true' naive CD4 + T cell population ( Supplementary Fig. 4b ). These data further suggest that the bystander inflammatory signals do not 'prepare' the Foxp3 locus for responsiveness by altering DNA methylation.
In agreement with the patterns of molecular activation described above, IC T N DR cells produced less IFN-γ than control cells when cultured in nonskewing conditions ( Fig. 4c) . When we supplemented culture with TGF-β, we observed low IL-17A production, and this was increased upon addition of IL-6 (ref. 24 ). In both cases, IC T N DR cells produced significantly less IL-17A cytokine, even when Foxp3 expression was nearly abolished by addition of IL-6 ( Fig. 4d) . We did not observe changes in expression of the TGF-β receptor ex vivo or activation of the signal transducers SMAD2 or SMAD3 with addition of exogenous TGF-β ( Supplementary Fig. 4c,d) , which suggests that molecular coordination amplifies the effect of existing TGF-β signaling components in IC T N cells. Together, these data show that naive CD4 + T cells exposed to bystander inflammation before antigen encounter exhibit enhanced de novo T reg cell differentiation. npg IC T N T reg cell differentiation follows viral infection and IFN-I Poly(I:C) is commonly used as an adjuvant that mimics the effects of viral infection. To address whether enhanced T reg cell induction occurs in a setting of bystander activation during a viral infection, we transferred DR cells into BALB/c hosts, which we then infected with lymphocytic choriomeningitis virus (LCMV). At various times after infection we then isolated CD4 + T cells from these mice and cultured them with OVA peptide-pulsed APCs and TGF-β, similarly to the approach we used with poly(I:C) above. Induced T reg cell differentiation was significantly increased in DR cells from mice infected for 7 d, as compared to earlier and later time points ( Fig. 5a and data not shown). Although the timing of this effect differed between poly(I:C) treatment and LCMV infection, it is notable that the kinetics of innate inflammatory cytokine expression are such that enhanced T reg cell differentiation occurred soon after the peak of the in vivo inflammatory responses of each of these treatments 25, 26 . Notably, whereas poly(I:C) and the TLR7 ligand gardiquimod conditioned native T cells for enhanced T reg cell induction, lipopolysaccharide (LPS) did not mediate this effect, which suggests a role for the qualitative nature of the inflammatory milieu in this response (Supplementary Fig. 5a ).
Poly(I:C) and LCMV specifically activate a substantial IFN-I response 27 . Consistent with a role for IFN-I, incubation of splenocytes with poly(I:C) resulted in enhanced de novo T reg cell induction that was blocked by neutralizing antibody against the receptor IFNAR1 (Supplementary Fig. 5b) . Next, we assessed T reg cell induction in IFNAR1-deficient (Ifnar1 KO ) DR mice treated with poly(I:C). In contrast to wild-type DR cells, Ifnar1 KO DR cells did not show enhanced T reg cell induction or diminished T eff cell differentiation after poly(I:C) treatment ( Fig. 5b and Supplementary Fig. 5c ), which demonstrates a clear dependence on IFN-I signals for this response. IC T N DR cells showed high expression of Socs1, which indicates that expression of these feedback molecules is a consequence of IFNAR1 signaling. Consistent with the consequent upregulation of these negative feedback molecules, and despite similar Ifnar1 and Ifnar2 expression, IC T N DR cells showed lower STAT1 activation after exposure to IFN-β ( Supplementary Fig. 5d,e ). When naive DR spleen cells were cultured in vitro with IFN-β, subsequent de novo T reg cell induction was enhanced (Fig. 5c) , which indicates that IFN-I alone is sufficient to elicit this response. A number of anti-inflammatory pathways are induced in response to IFN-I signals, including IL-10, PD-L1 and indolamine-2,3-dioxygenase (IDO). Neutralization of IL-10 or PD-L1 by treatment with blocking antibodies did not abrogate the enhanced Foxp3 induction in IC T N cells ( Supplementary  Fig. 5f ), nor did treatment with IDO inhibitor 1-methyltryptophan (1-MT) (Supplementary Fig. 5g ). Furthermore, although we observed expression of PD-L1 on IC T N cells, we were unable to detect expression of Foxa1 mRNA, which has been described as a mediator of IFN-I-regulated tolerance 28 (data not shown).
To determine whether IFN-I has a direct role on naive CD4 + T cells to condition for enhanced T reg cell induction, we transferred wild-type or Ifnar1 KO DR CD4 + T cells into wild-type or Ifnar1 KO BALB/c host mice. These mice were treated with poly(I:C), and T cells were cultured with OVA-pulsed APCs and TGF-β. Using Ly6C as a surrogate marker for bystander inflammation among the donor DR cells 29 , we observed that wild-type DR cells were responsive to bystander inflammatory signals in both wild-type and Ifnar1 KO host environments, whereas Ifnar1 KO DR cells showed only mild activation in the wild-type hosts and no activation in Ifnar1 KO hosts (Supplementary Fig. 5h ). Despite the apparent acquisition of some IFN-I-mediated bystander activating signals, we observed enhanced T reg cell induction only among wild-type DR cells in the wild-type host environment for IC T N cells versus controls (Fig. 5d) , which suggests a role for IFN-I signaling in multiple cell types for coordination of this effect. In contrast, direct IFN-I signals seemed to be involved in the conditioning of naive CD4 + T cells for diminished effector activity (Supplementary Fig. 5i) . Notably, direct IFN-I signals seemed to inhibit de novo T reg cell differentiation basally, such that conditioning by bystander inflammation did not further enhance Foxp3 induction in Ifnar1 KO DR cells.
Together, these data indicate that after bystander inflammation via IFN-I, naive CD4 + T cells are refractory to further proinflammatory signals and are conditioned for enhanced Foxp3 + T reg cell induction. This effect may be due to a partially a cell-intrinsic homeostatic mechanism to limit basal T reg cell induction, perhaps as a mechanism to enable an IFN-I-mediated semi-'primed' state for immune responsiveness 30 . In the wake of inflammatory settings, APCs or stromal cells in the microenvironment that receive IFN-I signals enable an interaction that imparts a state of enhanced receptivity to T reg cell-inducing signals, such that a dynamic state of immune tolerance and increased frequency of T reg cell differentiation is revealed after bystander inflammation. 
IC T N cell control of antigen-specific response via Foxp3
CD4 + helper T cells have a key role in promoting tumor immunity 31 . However, immunosuppressive mechanisms employed by tumors can support the recruitment and induction of T reg cells that can suppress tumor-specific responses 32, 33 . To demonstrate the role of bystander inflammation directly on antigen-specific naive CD4 + T cells in an antitumor response, enriched IC T N DR cells or control DR cells from PBS-treated mice were transferred into BALB/c hosts, which were then immunized and challenged with OVA-expressing A20 lymphoma cells. BALB/c recipients of IC T N DR cells showed more robust tumor growth than recipients of control DR cells ( Fig. 6a and Supplementary Fig. 6a ), which indicates a direct role for antigen-specific CD4 + T cell suppression of the antitumor response. Notably, this effect was reversed with Foxp3-deficient scurfy DR donors ( Fig. 6b and Supplementary Fig. 6b ), which indicates that Foxp3 induction is critical for enhanced tumor tolerance by IC T N CD4 + T cells.
To better define the role of the antigen-specific naive CD4 + T cell response, we next turned to a model of autoimmune diabetes. In this model, the only T cells present in Rag2-deficient mice expressing membrane-bound OVA under control of a pancreatic islet-specific rat insulin promoter (RIP-mOva × Rag2 KO host) are donor DR CD4 + T cells, and induction of donor T reg cells is crucial for islet tolerance 8 . Poly(I:C)-mediated bystander inflammation triggered islet autoimmunity and undermined Foxp3 induction in this setting when islet-specific control naive CD4 + T cells encountered antigen 8 (Fig. 6c) . In contrast, when DR cells were exposed to poly(I:C)induced inflammation before antigen exposure to generate IC T N cells, untreated host RIP-mOva-Rag2 KO mice showed very low incidence of diabetes 8 (Fig. 6c) . When scurfy DR mice were used as donors, all mice became diabetic regardless of treatment, which underscores the importance of Foxp3 for tolerance in this situation (Supplementary Fig. 6c) . To test the tolerogenic capacity of IC T N DR cells, control DR cells from PBS-treated mice or IC T N DR cells were transferred into RIP-mOva-Rag2 KO host mice, which were then treated with poly(I:C) (Supplementary Fig. 6d) . In contrast to recipients of control cells, recipients of IC T N DR cells had normal blood glucose concentrations at day 20 after transfer (Fig. 6d) . Furthermore, Foxp3 + T reg cell frequencies were higher among the IC T N donor DR cells than controls, which demonstrates that this process of enhanced T reg cell induction after bystander inflammation can occur even in conditions that are highly unfavorable to Foxp3 induction (Fig. 6e) . Figure 6 Bystander inflammation conditioning of naive CD4 + T cells inhibits antigen-specific CD4 + T cell responses in a Foxp3-dependent manner. (a,b) Tumor growth in BALB/c host mice transplanted with CD4 + T cells from control (ctr) or poly(I:C)-treated (pIC) DR mice (a) or Foxp3mutant scurfy (sf) DR CD4 + T cells (b), immunized with OVA peptide and inoculated subcutaneously 7-10 d later with A20-tGO lymphoma cells. Thin lines represent measurements from individual mice, thick lines represent mean. (c) Diabetes-free survival in RIP-mOva-Rag2 KO host mice that received IC T N DR cells and were left untreated (donor pIC) or received ctr DR cells and were injected with pIC (host pIC). (d,e) Blood glucose concentrations (d) and frequency of Foxp3 + donor DR cells in pancreatic lymph nodes (e) 20 d after pIC treatment of RIP-mOva-Rag2 KO host mice that received ctr or IC T N DR CD4 T cells ( Supplementary Fig. 6d) . Each symbol represents a single mouse; horizontal bars represent group mean; representative data from one of two independent experiments, n = 3 mice per group. *P < 0.05, **P < 0.0005, ***P < 0.0001, two-way ANOVA (a,b) or Student's two-tailed t-test (c). Data are compiled from three independent experiments with n = 14 mice per group (a) or from two independent experiments, n = 10 (b,c). Supplementary Fig. 7a ). npg A r t i c l e s Timing of inflammation controls IC T N response Our findings suggest that the timing of bystander inflammation relative to antigen encounter is involved in the determination of T reg and T eff cell differentiation. Indeed, comparison of cultured DR cells from mice treated with poly(I:C) alone or poly(I:C) plus OVA peptide showed that T reg cell induction was diminished by concurrent signals and enhanced by decoupling of signals ( Fig. 7a) . To investigate the temporal role of bystander inflammation relative to antigen encounter, we transferred DR cells into BALB/c host mice, which were then administered injections of poly(I:C) at one of six time points (from 5 d before to day of lymphocyte harvest). Lymphocytes were then harvested and cultured with OVA-pulsed APCs in the presence of TGF-β (Supplementary Fig. 7a) . Expression of PD-L1, CD69 and Ly6C-surface molecules associated with antigenindependent bystander inflammation-was transient in donor DR cells (Supplementary Fig. 7b ). Donor DR cell frequencies were consistent among all time points, which indicates that these cells are not subject to substantial attrition after bystander inflammation (Supplementary Fig. 7c) . Notably, assessment of intracellular Foxp3 and IFN-γ abundance indicated that T eff cell differentiation was markedly enhanced when bystander inflammation and antigen encounter were temporally coordinated (time point 0), whereas T reg cell induction was enhanced when inflammation and antigen encounter were separated by 2-3 d; expression of both markers returned to levels similar to that in PBS-treated controls at the latest time points (Fig. 7b) . This effect was confirmed in vivo using antigen-specific T reg cell induction by oral antigen delivery (Fig. 7c) . Furthermore, proliferation of induced T reg cells, but not Foxp3 − cells, was enhanced by exposure to bystander inflammation before antigen; this further supports a role for pre-exposure to inflammation in the increased numbers of induced Foxp3 + T reg cells upon cognate antigen recognition (Fig. 7d,e ). Together, these data show that nonspecific bystander inflammation can condition naive CD4 + T cells to 'favor' T eff cell or T reg cell differentiation under different circumstances, and this conditioning is linked to the relative timing of antigen and inflammatory signals.
DISCUSSION
In this study we sought to determine how nonspecific bystander inflammation in the absence of cognate antigen stimuli affects CD4 + T cell responses. Our results show that the process of bystander inflammation can inhibit the immune response to antigen by conditioning of naive CD4 + T cells to be refractory to T eff cell differentiation and to enhance T reg cell induction. We showed that the effect of such bystander conditioning can be modulated by the temporal relationship of the inflammation and antigen signals such that coordinated signals undermine T reg cell induction and temporally decoupled signals enhance T reg cell induction. These results suggest a paradigm for T cell priming signals and reveal an underlying principle for the apparent duality of the role of innate inflammation as both a driver and inhibitor of T cell responses 12, 13 . The effects of bystander inflammation on subsequent T cell differentiation were greatest at suboptimal differentiation conditions. This characteristic would be consistent with the idea that the refractory state of naive T cells after bystander inflammation acts as a temporary buffer to prevent unwanted autoimmune responses while still preserving the ability to adjust immune responses according to need. Notably, impaired antitumor immunity in the presence of IC T N DR cells was reversed when these cells did not express functional Foxp3. This would suggest that Foxp3 itself has an important role as a component of a 'master switch' molecular complex that guides T reg cell differentiation in IC T N CD4 + T cells. Furthermore, our findings supports the idea that pro-effector molecular factors are also mobilized in this process and that the end result of T cell differentiation depends on the balance of these factors 34 . Although our results do not directly demonstrate a Foxp3-dependent control switch for T eff versus T reg cell induction in this context, lineage-tracing approaches support the idea that transient low-level de novo Foxp3 expression occurs in CD4 + T cells in inflammatory contexts 35 .
Bystander inflammation conditioning of naive CD4 + T cells was dependent on IFN-I, a critical component of TLR-mediated optimization of T cell responses 36 . Our adoptive transfer experiments suggest that IFN-I signals can have a direct role on antigen-specific CD4 + T cells as well as other cells in the microenvironment to mediate anti-and pro-induction effects on Foxp3. Although not as apparent in monoclonal DR Ifnar1 KO mice, this effect was revealed in the context of the lymphoreplete environment, which suggests a role for other lymphocyte subsets (such as B cells and T reg cells) for this effect. Upon enhanced IFN-I signal during poly(I:C)-mediated bystander inflammation, IFN-I signal action on the surrounding cells in the microenvironment mediated a release of this basal inhibition of Foxp3, resulting in an apparent increase in frequency of de novo T reg cell induction among wild-type DR cells. IFN-I has a complex role as an immunomodulatory cytokine, both as a promoter and inhibitor of antigen-specific immune responses 37 . In the Clone 13 model of chronic LCMV infection, IFN-I receptor blockade can initiate CD4 + T cell-dependent viral clearance 38, 39 . Additionally, the immunosuppressive role of IFN-I in chronic LCMV has been linked to suppression of mechanisms of type I T eff cell differentiation 40, 41 . These studies have demonstrated a clearly reversible refractory state. Similarly, we have shown that the same bystander inflammatory response can undermine or enhance T reg cell induction, depending on its temporal relationship with antigen encounter. These lines of evidence suggest the possibility that quiescent naive CD4 + T cells adjust the qualitative nature of their response to antigen in a dynamic manner that corresponds to temporal windows defined by environmental cues.
The physiological impact of the differentiation outcomes for IC T N CD4 + T cells has notable ramifications for health and disease. The results presented here highlight a dimension of CD4 + T cell biology, namely the ability of naive T cells to modulate response to antigen by integration of signals over time. This type of molecular coordination probably evolved to mitigate potential for autoimmunity after cellular damage and release of self-antigens during infection. Indeed, epidemiological data support the notion that environmental conditioning of the immune system by infection diminishes the aberrant immune responses that lead to autoimmunity 42 . The flip side of this immunoregulatory process is enhanced susceptibility to heterologous superinfection and immune escape of tumors. As the antiparallel to autoimmunity, tumor immunity is similarly complicated by conflicting roles for the immunomodulatory role of inflammatory responses 43, 44 . The interplay of inflammatory processes acting in trans on the homeostatic immune and tissue-supporting microenvironment may even have an important role in early progression of tumorigenesis 45, 46 . It is conceivable that the process of tumorigenesis in the context of infectious or tumor-derived inflammation could be enhanced by conditioning of newly infiltrating naive T cells for de novo T reg cell induction during the process of immunoediting. Such an effect could partially account for the relentless growth and metastasis of tumors despite relatively high levels of immune cell infiltration compared to healthy tissues.
Crucial for an effective but nonharmful immune response by T cells is the integration of positive and negative feedback signaling over time. By providing signals to alter the quality of responses npg during the course of a response to infection, we propose that the inflammatory milieu produced by innate immune mechanisms coordinates effector and regulatory lymphocyte responses as a series of waves that promote both immunity and self-tolerance. As an evolutionary adaptation, this process is probably a component of the 'metastable equilibrium' that enables sustainable levels of viral control without deleterious immunopathology during intractable chronic infection 47 . These concepts may be useful for lending nuance to vaccine and immunotherapeutic approaches to achieve more finely tuned outcomes.
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Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
